Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
70 studies found for:    "progressive familial intrahepatic cholestasis" OR "Cholestasis, Intrahepatic"
Show Display Options
Rank Status Study
1 Recruiting Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention: Drug: LUM001
2 Recruiting Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease
Conditions: Alagille Syndrome;   Progressive Familial Intrahepatic Cholestasis
Intervention:
3 Completed Induction of Labor in Intrahepatic Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis
Intervention:
4 Completed Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis;   Pregnancy
Interventions: Drug: ursodeoxycholic acid;   Drug: Placebo
5 Withdrawn The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention: Dietary Supplement: Fish Oil Supplement Group
6 Recruiting Il-17 Levels in Intrahepatic Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention:
7 Completed ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention:
8 Active, not recruiting Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Condition: Intrahepatic Cholestasis Associated With Alcoholic Liver Disease
Interventions: Drug: Ademetionine IV+tablet;   Drug: Ademetionine tablet
9 Recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, Intrahepatic
Interventions: Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acid
10 Recruiting P-wave Duration and Dispersion in Intrahepatic Cholestasis of Pregnancy
Conditions: Intrahepatic Cholestasis of Pregnancy;   Arrhythmia
Intervention:
11 Unknown  Ursodeoxycholic Acid And Cholestasis Of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Interventions: Drug: Ursodeoxycholic Acid;   Drug: Placebo
12 No longer available Buphenyl Therapy for Byler's Disease
Condition: Byler Disease
Intervention: Drug: Buphenyl
13 No longer available Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Condition: Byler Disease
Intervention: Drug: Glycerol phenylbutyrate
14 Temporarily not available Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
Condition: Byler Disease
Intervention: Drug: RAVICTI
15 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
Intervention:
16 Terminated Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Condition: Cholestasis, Progressive Familial Intrahepatic 3
Intervention: Device: Yttrium microsphere injection
17 Unknown  Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Condition: Hepatobiliary Diseases
Intervention:
18 Completed Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis;   Hypercholesterolemia
Intervention: Drug: Atorvastatin
19 Completed Moexipril for Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: Moexipril
20 Withdrawn Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
Conditions: Primary Biliary Cirrhosis;   Autoimmune Hepatitis
Intervention: Drug: Budesonide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years